Parenteral Manual

Tuberculin

Disclaimer: Official controlled document is the CHEO online copy. It is the responsibility of user to ensure that any paper copy version is the same as the online version before use.

Alternate Name(s): 
TTB skin test, MANTOUX, PPD
Classification: 
TB skin test
Original Date: 
August 2005
Revised Date: 
Indications: 
  • An aid in the detection of infection with Mycobacterium tuberculosis
Reconstitution and Stability: 
  • Available as 5 test units/0.1 mL dose
  • Vial stable 1 month refrigerated once punctured. Protect from light
Compatibility: 

- DO NOT mix with any other drug or IV fluid

Administration: 

(For approved routes of administration by nursing personnel, refer to Policy for the Administration of Intravenous Medications.)

Intracutaneous YES
Intradermal YES
  • Avoid subcutaneous injection
Dosage: 

(For neonatal dosages, refer to Neonatal IV Drug Manual.)

  • 5 test units (0.1 mL) intracutaneously
Potential hazards of parenteral administration: 
  • Vesiculation, ulceration or necrosis at test site in sensitive patients
  • Pain, pruritus and discomfort
  • Erythematous reactions at injection site
  • Hypersensitivity reactions
Notes: 
  • The test should be read 48-72 hours after administration; sensitivity is indicated by induration, usually accompanied by erythema
  • Widest diameter of distinctly palpable induration is recorded in millimetres (mm)

Positive reaction:

 >10 mm

Doubtful reaction: 

5-9 mm; if known contacts considered positive reaction

Negative reaction: 

< 5 mm
References: 

The information contained on this website is provided for informational purposes only, as a guide to assist physicians, nurses and other healthcare providers in deciding on the appropriate care required for a particular patient. At all times, physicians, nurses and other healthcare providers must exercise their independent clinical judgment, based on their knowledge, training and experience, taking into account the specific facts and circumstances of each patient, when deciding on the appropriate course of investigation and/or treatment to recommend in a particular clinical situation.

CHEO has made every effort to ensure that the information contained on this website is as current and accurate as possible. However, changes can occur due to ongoing research and the constant influx of new information. Where possible, hospitals and healthcare practitioners should verify the information before acting on it.

Reliance on any information in this website is at the user's own risk. CHEO is not responsible or liable for any harm, loss or other consequences from the use or misuse of the information on this website.